CEMI News and Press, Chembio Diagnostics Inc. From 01/14/21

Express (EXPR) +62% as company lines up new financing.DPW Holdings (DPW) +57% as pre-orders for residential level 2 EV chargers have begun on Amazon.Pingtan Marine Enterprise (PME) +43% on announcing FY 2021 guidance.ZW Data Action Technologies (CNET) +38%. after the company wa...

Chembio Diagnostics (CEMI) rises 10% in premarket on the heels of CE mark approval for its DPP SARS-CoV-2 antigen and IgM/IgG test systems in the European Union.The company also entered into an exclusive U.K. and Ireland distribution pact with Luas Diagnostics, which will ...

HAUPPAUGE, N.Y., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the CE mark for the DPP SARS-CoV-2 Antigen and IgM/IgG test systems, providing regulatory approval to ...

The virus shows no signs of slowing. At the moment, there are 82.9 million cases of the virus. In the U.S., the case load is up to 19.7 million. Making matters worse, there’s now a new strain of the virus popping up in the UK. Colorado, and in California. In addition, according to Dr...

HAUPPAUGE, N.Y., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Acheson, M.D. to the Company’s Board of Directors. “We ar...

Gainers: China HGS Real Estate (HGSH) +136%.Pioneer Power Solutions (PPSI) +54%.Star Peak Energy Transition (STPK) +45%.Fangdd Network Group (DUO) +41%.Sutro Biopharma (STRO) +35%.Collective Growth (CGROU) +34%.CIIG Merger (CIIC) +31%.Collective Growth (CGRO) +27%.AquaBounty Technologies...

Chembio Diagnostics (CEMI) is down 13% premarket on increased volume in response to its disclosure that the FDA will not prioritize its application for emergency use authorization ((EUA)) of its DPP SARS-CoV-2 IgM/IgG antibody blood test that is performed on its DPP Micro Reader.In ...

Chembio Diagnostics (CEMI) slips 11% in premarket, as the FDA has declined to review the company's emergency use authorization ((EUA)) application for a rapid antibody test system, DPP SARS-CoV-2 IgM/IgG.The letter cited that the review of the IgM/IgG request is not a priority ...

The U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority ((BARDA)) has awarded a $12.7M contract to Chembio Diagnostics ([[CEMI]] +8.8%) to support the development and U.S. emergency use nod for a rapid DPP respiratory antigen panel point-of-car...

HAUPPAUGE, N.Y., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) a leading point-of-care diagnostic company focused on infectious diseases, today announced it has been awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA),...